학술논문
Progression-free Survival After Second Line of Therapy for Metastatic Clear Cell Renal Cell Carcinoma in Patients Treated with First-line Immunotherapy Combinations
Document Type
Short Communication
Author
Source
In European Urology March 2023 83(3):195-199
Subject
Language
ISSN
0302-2838